+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
21.10.2024 15:09:05

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

Tuesday, 5 November 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financial results and answer questions from investors and financial analysts.
A presentation will be available on Coloplast's website approximately 1 hour before the conference call.
Please note that the webcast of the conference call will be available during and after the event.

Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations 


Webcast
Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:

Access the webcast here

 


Dial-in details
For analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details: 

Register here

 

For more information, please contact:

Aleksandra Dimovska, Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458, e-mail: dkadim@coloplast.com

Kristine Husted Munk, Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266, e-mail: dkkhu@coloplast.com

Julie Sommer Müggler, Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161, e-mail: dkjusm@coloplast.com

Konstancija Norvilaite, Associate IR & Finance Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2803, e-mail: dkkono@coloplast.com


 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment


Analysen zu Coloplast A-S (B)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Coloplast A-S (B) 120,50 2,95% Coloplast A-S (B)